Literature DB >> 6603621

Long-term growth of human B cells and their use in a microassay for B-cell growth factor.

A L Maizel, J W Morgan, S R Mehta, N M Kouttab, J M Bator, C G Sahasrabuddhe.   

Abstract

Normal human B lymphocytes, prepared from peripheral venous blood, have been stimulated with intact anti-IgM (mu chain specific) bound to an insoluble matrix. The activation event, in a subfraction of human B cells, was associated with subsequent receptivity to the mitogenic effects of exogenously added B-cell growth factor. The ability of the cell population to specifically absorb the B-cell growth factor was dependent upon the time of stimulation with the anti-IgM. Continuous replenishment of the growth factor resulted in the ability to maintain long-term growth-factor-dependent human B-cell populations. These cultured B lymphocytes were shown to specifically absorb the B-cell growth factor, suggesting the presence of membrane receptors for it. The cultured B lymphocytes were routinely maintained in logarithmic-phase growth, in the presence of growth factor, with a population doubling time of 36 hr. These cultured B cells have been utilized in a microassay for the assessment of B-cell growth factor activity that is accurate, sensitive, and precise.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603621      PMCID: PMC384185          DOI: 10.1073/pnas.80.16.5047

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  A mitogen for human B cells: anti-Ig coupled to polyacrylamide beads activates blood mononuclear cells independently of T cells.

Authors:  J J Fothergill; R Wistar; J N Woody; D C Parker
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

2.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

Authors:  M Howard; J Farrar; M Hilfiker; B Johnson; K Takatsu; T Hamaoka; W E Paul
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

3.  Induction of murine B cell proliferation by insolubilized anti-immunoglobulins.

Authors:  E Puré; E Vitetta
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

4.  Soluble factor activation of human B lymphocytes.

Authors:  R J Ford; S R Mehta; D Franzini; R Montagna; L B Lachman; A L Maizel
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

5.  Biochemical separation of a human B cell mitogenic factor.

Authors:  A Maizel; C Sahasrabuddhe; S Mehta; J Morgan; L Lachman; R Ford
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

Review 6.  Display and analysis of flow cytometric data.

Authors:  J W Gray; P N Dean
Journal:  Annu Rev Biophys Bioeng       Date:  1980

7.  Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors.

Authors:  K Yoshizaki; T Nakagawa; T Kaieda; A Muraguchi; Y Yamamura; T Kishimoto
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

8.  Activation of mouse lymphocytes by anti-immunoglobulin. I. Parameters of the proliferative response.

Authors:  D G Sieckmann; R Asofsky; D E Mosier; I M Zitron; W E Paul
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

9.  Long-term culture and cloning of nontransformed human B lymphocytes.

Authors:  B Sredni; D G Sieckmann; S Kumagai; S House; I Green; W E Paul
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

10.  T cell growth factor receptors. Quantitation, specificity, and biological relevance.

Authors:  R J Robb; A Munck; K A Smith
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  16 in total

1.  Low MW B-cell growth factor potentiates histamine release from human basophil leucocytes.

Authors:  A Tedeschi; M G Roncarolo; M Lorini; A Miadonna
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

2.  Antigen-independent regulation of cytoplasmic calcium in B cells with a 12-kDa B-cell growth factor and anti-CD19.

Authors:  J A Ledbetter; P S Rabinovitch; C H June; C W Song; E A Clark; F M Uckun
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

3.  Response of neoplasms of B cell lineage to the proliferative effects of B cell growth factor and the phorbol ester TPA.

Authors:  M C Kinney; R D Collins; J Whitlock; J B Cousar; L B Vogler
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

4.  Intimate host-tumor interaction in the spontaneous reticulum cell sarcoma of SJL/J mice: is it an exceptional case?

Authors:  B Bonavida
Journal:  Surv Immunol Res       Date:  1985

5.  Induction of c-myc expression in human B lymphocytes by B-cell growth factor and anti-immunoglobulin.

Authors:  J Lacy; S N Sarkar; W C Summers
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

6.  Human B lymphoma cell line producing B cell growth factor.

Authors:  J L Ambrus; A S Fauci
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

7.  Evidence for an intracellular precursor for human B-cell growth factor.

Authors:  C G Sahasrabuddhe; J Morgan; S Sharma; S Mehta; B Martin; D Wright; A Maizel
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

8.  Stimulation of lymphoid cell proliferation by Mycoplasma orale, a common cell culture contaminant.

Authors:  Y Mizushima; J Quintans; E P Cohen
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

9.  Antibodies to the T3 antigen complex on human T cells render thymocytes unresponsive to mitogen.

Authors:  G F Burns; A W Boyd; J A Werkmeister; T Triglia; P Andrews
Journal:  Immunology       Date:  1985-05       Impact factor: 7.397

10.  The specific induction of myc protooncogene expression in normal human B cells is not a sufficient event for acquisition of competence to proliferate.

Authors:  E Smeland; T Godal; E Ruud; K Beiske; S Funderud; E A Clark; S Pfeifer-Ohlsson; R Ohlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.